New MRI method may spare kidney patients unnecessary biopsies

NCT ID NCT06126159

Ongoing Diagnosis Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special MRI can tell the difference between harmless and cancerous kidney growths when standard CT scans cannot see fat. About 44 adults with kidney masses that have no visible fat on CT will get this advanced MRI. The goal is to see if the MRI can identify tumor types and guide treatment without needing a needle biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multiparametric and fat-detection magnetic resonance imaging (MRI)
What this could lead to: If successful, this MRI method could help doctors diagnose kidney tumor types without needing a biopsy, guiding treatment decisions more safely.
What could go wrong: This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The MRI technique may not be accurate enough to replace biopsy in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

angiomyolipoma kidney cancer kidney neoplasm renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY NEOPLASMS

Contacts and locations

Locations

Li-Jen Wang

Taoyuan, Taiwan, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.